Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Study: New Engineered Particles Train the Body to Accept Allergens

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Eczema Drug Makes Significant Progress as EoE Treatment

DBV Completes Phase III Study of Peanut Patch

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

New Gene Therapy Could Retrain Immune System to 'Forget' Allergy

New Cancer Treatment May Prove Effective Against Food Allergies

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Your School On Our Map

Put Your School on the Map